ACI 9th Annual Summit On Biosimilars: Evaluating Ethical Concerns for the Biologics Industry - McCabe Ali LLP Law Skip to content Main Menu Practice Areas Menu Toggle IP Ethics & USPTO Discipline Investment Advisor Registration & Compliance Professional Licensure Commercial Litigation Why Us Menu Toggle Why Us Speaking Engagements Published Works In the News Professionals Menu Toggle Emil J. Ali Michael E. McCabe, Jr Blog Menu Toggle IPEthics & INsights Investment Advisor Compliance CLE Contact Us Search for: Search Main Menu Practice Areas Menu Toggle IP Ethics & USPTO Discipline Investment Advisor Registration & Compliance Professional Licensure Commercial Litigation Why Us Menu Toggle Why Us Speaking Engagements Published Works In the News Professionals Menu Toggle Emil J. Ali Michael E. McCabe, Jr Blog Menu Toggle IPEthics & INsights Investment Advisor Compliance CLE Contact Us Search for: Search June 26, 2018 ACI 9th Annual Summit On Biosimilars: Evaluating Ethical Concerns for the Biologics Industry Event Time: Location: 4:00 - 5:00 PM EST New York, NY About the event American Conference Institute’s 9th Annual Summit on Biosimilars Evaluating Ethical Concerns for the Biologics Industry – featuring Michael E. McCabe, Jr. (McCabe Law), Mark Waddell (Loeb & Loeb) & the Honorable Teresa Rea (Crowell & Moring) June 26, 2018 from 4:00 – 5:00 PM EST New York, NY One (1) hour of ethics CLE Posted in Continuing Legal Education, IP Ethics, IP Ethics CLE, Patent Ethics CLE, Previous, Speaking Engagements Read more about IP ETHICS with McCabeAli IP Ethics Practice Contact Info Office Phone: (571) 669-4097 Email: info@mccabeali.com Michael E. McCabe, Jr: Washington D.C. Area Office Emil J. Ali: Los Angeles Area Office Schedule a Consultation Schedule Online Social Info © 2022 McCabe & Ali, LLP | McCabe//Ali means McCabe & Ali, LLP | All Rights Reserved | Privacy Policy | Disclaimer Scroll to Top